Paste your Google Webmaster Tools verification code here
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer Brian Leyland-Jones, Kathryn P. Gray, Mark Abramovitz, Mark Bouzyk, Brandon Young, Bradley Long, Roswitha Kammler, Patrizia Dell’Orto, Beat Thürlimann, Vernon Harvey, Patrick Neven, Laurent Arnould, Rudolf Maibach, Karen N. Price, Alan S. Coates, Aron
Read More
AKESOgen scientists attend the Personalized Medicine World Conference 2016 in the Computer History Museum, Mountain View, CA, January 25 – 27, 2016. Please email info@akesogen.com or call 770 542 0890 to discuss your genomics needs. Share this